Anixa Biosciences Inc (ANIX) stock
ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
$2.67+0.12 (+4.71%)
Close on Nov 17, 2026Market cap $92.82MP/E –Yield –
Anixa Biosciences price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Anixa Biosciences's price to book ratio was 6.6× on Nov 11, 2026, against 9.1× a year earlier. Over the last 5 years it ranged from 2.4× to 9.1×, with a median of 4.7×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 6.6× | −0.1 |
| 2025 | Dec 31, 2025 | 6.8× | +3.1 |
| 2024 | Dec 31, 2024 | 3.7× | −1.2 |
| 2023 | Dec 29, 2023 | 5.0× | +0.4 |
| 2022 | Dec 30, 2022 | 4.5× | +2.0 |
| 2021 | Dec 31, 2021 | 2.5× | −6.0 |
| 2020 | Dec 31, 2020 | 8.5× | −4.2 |
| 2019 | Dec 31, 2019 | 12.7× | −1.0 |
| 2018 | Dec 31, 2018 | 13.7× | +8.8 |
| 2017 | Dec 29, 2017 | 4.9× | −42.9 |
| 2016 | Dec 30, 2016 | 47.9× | +42.7 |
| 2015 | Dec 31, 2015 | 5.2× | −0.8 |
| 2014 | Dec 31, 2014 | 6.0× | −23.3 |
| 2012 | May 31, 2012 | 29.3× | +11.0 |
| 2011 | Dec 30, 2011 | 18.3× | +11.3 |
| 2010 | Dec 31, 2010 | 7.0× | – |
See a number that looks wrong?